REGENXBIO Inc.

RGNXNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$170.4M

▲ 104.5% YoY

Net Income

-$193.9M

▲ 14.6% YoY

EPS

$-3.76

▲ 18.1% YoY

Cash

$34.5M

▼ 40.1% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.